Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Reiterates Overweight Rating on Centene (CNC)
-
Cantor Fitzgerald Reiterates Overweight Rating on Axsome Therapeutics (AXSM)
-
Cantor Fitzgerald Starts Coincheck Group N.V. (CNCK) at Overweight
-
Cantor Fitzgerald Downgrades Supernus Pharmaceuticals (SUPN) to Neutral
-
Howard Lutnick Confirmed as 41st United States Secretary of Commerce; Steps down from his positions at Cantor Fitzgerald, L.P.
-
Stephen Merkel named Chairman of BGC Group's Board of Directors
-
BGC Group announces John Abularrage, JP Aubin, and Sean Windeatt appointed Co-Chief Executive Officers
-
Stephen Merkel Appointed Chairman of Newmark's Board of Directors
-
Howard Lutnick Confirmed as 41st United States Secretary of Commerce; Steps Down as BGC Group Chairman of the Board and Chief Executive Officer
-
Howard Lutnick Confirmed as 41st United States Secretary of Commerce; Steps Down from Newmark Board and Executive Officer Position
-
US Senate confirms Cantor Fitzgerald's Lutnick to head Commerce Department
-
NeuroPace Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
-
Semler Scientific® Reports Fourth Quarter and Full Year 2024 Financial Results with a BTC Yield of 107% since July 1, 2024; Now holds 3,192 BTC
-
Form N-23C3A CANTOR FITZGERALD INFRAS For: Feb 18
-
Cantor Fitzgerald Reiterates Overweight Rating on Vera Therapeutics (VERA)
-
Intel (INTC) PT Raised to $29 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Western Digital Corp. (WDC)
-
Cantor Fitzgerald Reiterates Overweight Rating on Lam Research (LRCX)
-
Form 13F-NT CANTOR FITZGERALD & CO. For: Dec 31
-
Form 13F-NT Cantor Fitzgerald Europe For: Dec 31
-
Form 13F-HR CANTOR FITZGERALD, L. For: Dec 31
-
Form 13F-NT CANTOR FITZGERALD SECURI For: Dec 31
-
Cantor Fitzgerald Reiterates Overweight Rating on Avita Medical Ltd. (RCEL)
-
Cantor Fitzgerald Reiterates Overweight Rating on Udemy Inc (UDMY)
-
JFrog (FROG) PT Raised to $46 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Ultragenyx Pharma (RARE)
-
Cantor Fitzgerald Reiterates Overweight Rating on Palo Alto Networks (PANW)
-
Informatica (INFA) PT Lowered to $18 at Cantor Fitzgerald
-
GoDaddy Inc (GDDY) PT Lowered to $210 at Cantor Fitzgerald
-
Airbnb Inc. (ABNB) PT Raised to $130 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Vanda Pharmaceuticals (VNDA)
-
NeuroPace (NPCE) Announces Pricing of Public Offering of $65M of Common Stock
-
NeuroPace Announces Pricing of Public Offering of $65 Million of Common Stock
-
NeuroPace (NPCE) Announces $65M Proposed Share Offering
-
NeuroPace Announces Proposed Public Offering of $65 Million of Common Stock
-
Informatica Reports Fourth Quarter and Full-Year 2024 Financial Results
-
CyberArk Software (CYBR) PT Raised to $445 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Alkermes (ALKS)
-
Cantor Fitzgerald Reiterates Overweight Rating on CVRx Inc (CVRX)
-
Cantor Fitzgerald Reiterates Overweight Rating on Kornit Digital Ltd. (KRNT)
-
Cantor Fitzgerald Reiterates Overweight Rating on MKS Instruments (MKSI)
-
Cantor Fitzgerald Reiterates Overweight Rating on Tenet Healthcare (THC)
-
Cantor Fitzgerald Reiterates Overweight Rating on IREN Ltd. (IREN)
-
Rezolve AI (RZLV) to Acquire GroupBy
-
Rezolve Ai to Acquire GroupBy Strengthening Market Leadership in Commerce Site Search and Digital Engagement
-
The Trade Desk (TTD) PT Lowered to $100 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Aurora Innovation Inc (AUR)
-
Cantor Fitzgerald Starts GH Research PLC (GHRS) at Overweight
-
The Trade Desk (TTD) PT Lowered to $100 at Cantor Fitzgerald
-
Aardvark Therapeutics Announces Pricing of Initial Public Offering

